Table 2 |
|||||||
|
Effects of DMAB modification on size, entrapment efficiency and zeta potential |
|||||||
|
Group |
Polymer |
Size (nm) |
PDI |
Zeta Potential (mV) |
Drug loading (%) |
EE (%) |
DMAB Modification (%) |
|
|
|||||||
|
ANP |
PLGA |
239.82 ± 8.64 |
0.299 |
-28.58 ± 4.44 |
8.93 |
88.26 |
5 |
|
BNP |
PLGA-TPGS |
253.51 ± 5.38 |
0.264 |
-21.87 ± 2.11 |
9.83 |
98.27 |
None |
|
CNP |
PLGA-TPGS |
226.33 ± 3.56 |
0.251 |
32.23 ± 3.55 |
9.62 |
96.23 |
5 |
|
DNP |
PLGA-TPGS |
219.42 ± 5.24 |
0.199 |
34.15 ± 4.28 |
9.21 |
92.12 |
20 |
|
|
|||||||
|
PDI polydispersity index, EE drug entrapment efficiency, n = 3 |
|||||||
|
Chen et al. Nanoscale Res Lett 2011 6:4 doi:10.1007/s11671-010-9741-8 |
|||||||